RT Journal Article
T1 Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
A1 Zamora-Ros, Raul
A1 Alghamdi, Muath A
A1 Cayssials, Valerie
A1 Franceschi, Silvia
A1 Almquist, Martin
A1 Hennings, Joakim
A1 Sandström, Maria
A1 Tsilidis, Konstantinos K
A1 Weiderpass, Elisabete
A1 Boutron-Ruault, Marie-Christine
A1 Hammer Bech, Bodil
A1 Overvad, Kim
A1 Tjønneland, Anne
A1 Petersen, Kristina E N
A1 Mancini, Francesca Romana
A1 Mahamat-Saleh, Yahya
A1 Bonnet, Fabrice
A1 Kühn, Tilman
A1 Fortner, Renée T
A1 Boeing, Heiner
A1 Trichopoulou, Antonia
A1 Bamia, Christina
A1 Martimianaki, Georgia
A1 Masala, Giovanna
A1 Grioni, Sara
A1 Panico, Salvatore
A1 Tumino, Rosario
A1 Fasanelli, Francesca
A1 Skeie, Guri
A1 Braaten, Tonje
A1 Lasheras, Cristina
A1 Salamanca-Fernández, Elena
A1 Amiano, Pilar
A1 Chirlaque, Maria-Dolores
A1 Barricarte, Aurelio
A1 Manjer, Jonas
A1 Wallström, Peter
A1 Bueno-de-Mesquita, H Bas
A1 Peeters, Petra H
A1 Khaw, Kay-Thee
A1 Wareham, Nicholas J
A1 Schmidt, Julie A
A1 Aune, Dagfinn
A1 Byrnes, Graham
A1 Scalbert, Augustin
A1 Agudo, Antonio
A1 Rinaldi, Sabina
K1 Coffee
K1 Cohort
K1 EPIC
K1 Intake
K1 Tea
K1 Thyroid cancer
AB Coffee and tea constituents have shown several anti-carcinogenic activities in cellular and animal studies, including against thyroid cancer (TC). However, epidemiological evidence is still limited and inconsistent. Therefore, we aimed to investigate this association in a large prospective study. The study was conducted in the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, which included 476,108 adult men and women. Coffee and tea intakes were assessed through validated country-specific dietary questionnaires. During a mean follow-up of 14 years, 748 first incident differentiated TC cases (including 601 papillary and 109 follicular TC) were identified. Coffee consumption (per 100 mL/day) was not associated either with total differentiated TC risk (HRcalibrated 1.00, 95% CI 0.97-1.04) or with the risk of TC subtypes. Tea consumption (per 100 mL/day) was not associated with the risk of total differentiated TC (HRcalibrated 0.98, 95% CI 0.95-1.02) and papillary tumor (HRcalibrated 0.99, 95% CI 0.95-1.03), whereas an inverse association was found with follicular tumor risk (HRcalibrated 0.90, 95% CI 0.81-0.99), but this association was based on a sub-analysis with a small number of cancer cases. In this large prospective study, coffee and tea consumptions were not associated with TC risk.
YR 2018
FD 2018-12-10
LK http://hdl.handle.net/10668/13306
UL http://hdl.handle.net/10668/13306
LA en
DS RISalud
RD Apr 8, 2025